Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.
Ling AL, Gantchev J, Prabhu MC, Basu S, Ahn R, D'Souza A, Masud N, Ball A, Nikas O, Villa GR, Regan MS, Baquer G, Ayoub G, Whittaker CA, Abou-Mrad Z, Santos A, Couturier CP, Elharouni D, Vogelzang J, Yu KKH, Chen H, He Z, Jiang W, Lucas CH, Sax HE, Lang FF, Puduvalli VK, Tabar V, W Brennan C, Boire A, Holdhoff M, Bettegowda C, Cima M, Solomon IH, Yuan Y, Tak PP; Accelerating GBM Therapies TeamLab; Sharma P, White FM, Ligon KL, Agar NYR, Reardon DA, Oliveira G, Chiocca EA.
Ling AL, et al.
Sci Transl Med. 2025 Oct 8;17(819):eadv2881. doi: 10.1126/scitranslmed.adv2881. Epub 2025 Oct 8.
Sci Transl Med. 2025.
PMID: 41061048